CoChat

Effect of the Pre-erythrocytic Candidate Malaria Vaccine RTS,S/AS01E on Blood Stage Immunity in Young Children

Open access
Bejon, Philip, Cook, Jackie, Bergmann-Leitner, Elke, Olotu, Ally, Lusingu, John, Mwacharo, Jedidah, Vekemans, Johan, Njuguna, Patricia, Leach, Amanda, Lievens, Marc, Dutta, Sheetij, von Seidlein, Lorenz, Savarese, Barbara, Villafana, Tonya, Lemnge, Martha M., Cohen, Joe, Marsh, Kevin, Corran, Patrick H., Angov, Evelina, Riley, Eleanor M., Drakeley, Chris J. · 2011 · The Journal of Infectious Diseases
Cited by 72

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Background.RTS,S/AS01 E is the lead candidate malaria vaccine and confers pre-erythrocytic immunity.Vaccination may therefore impact acquired immunity to blood-stage malaria parasites after natural infection.Methods.We measured, by enzyme-linked immunosorbent assay, antibodies to 4 Plasmodium falciparum merozoite antigens (AMA-1, MSP-1 42 , EBA-175, and MSP-3) and by growth inhibitory activity (GIA) using 2 parasite clones (FV0 and 3D7) at 4 times on 860 children who were randomized to receive with RTS,S/AS01 E or a control vaccine.Results.Antibody concentrations to AMA-1, EBA-175, and MSP-1 42 decreased with age during the first year of life, then increased to 32 months of age.Anti-MSP-3 antibody concentrations gradually increased, and GIA gradually decreased up to 32 months.Vaccination with RTS,S/AS01 E resulted in modest reductions in AMA-1, EBA-175, MSP-1 42 , and MSP-3 antibody concentrations and no significant change in GIA.Increasing anti-merozoite antibody concentrations and GIA were prospectively associated with increased risk of clinical malaria. Conclusions.Vaccination with RTS,S/AS01E reduces exposure to blood-stage parasites and, thus, reduces antimerozoite antigen antibody concentrations.However, in this study, these antibodies were not correlates of clinical immunity to malaria.Instead, heterogeneous exposure led to confounded, positive associations between increasing antibody concentration and increasing risk of clinical malaria.Malaria remains a global health problem [1], despite the recent increase in insecticide-treated bed-net (ITN) provision and highly effective artemisinin combination therapy [2][3][4].A malaria vaccine is needed for sustained control.RTS,S is a candidate malaria vaccine based on the circumspozoite protein (CSP) that targets the preerythrocytic cycle of Plasmodium falciparum in humans [5].Vaccination with RTS,S has been partially efficacious against clinical malaria in the field when given with either the AS01 or AS02 adjuvant system [6,7].RTS,S-containing vaccines induce pre-erythrocytic immunity [8], differing from naturally acquired immunity, which largely targets blood-stage parasites [9].

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/infdis/jir222

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 72

Metadata

Authors
Bejon, P., Cook, J., Bergmann-Leitner, E., Olotu, A., Lusingu, J., Mwacharo, J., Vekemans, J., Njuguna, P., Leach, A., Lievens, M., Dutta, S., von Seidlein, L., Savarese, B., Villafana, T., Lemnge, M. M., Cohen, J., Marsh, K., Corran, P. H., Angov, E., Riley, E. M., & Drakeley, C. J.
Venue
The Journal of Infectious Diseases
Published
2011-07-01
Volume
204
Issue
1
Pages
9-18
ISSN
  • 0022-1899 (ISSN-L)
  • 1537-6613
OpenAlex
W2155662187
Cited by
72
References
3
FWCI
7.35
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of the Pre-erythrocytic Candidate Malaria Vaccine RTS,S/AS01E on Blood Stage Immunity in Young Children. https://app.cochat.ai/papers/10.1093/infdis/jir222
The paper
Bejon, P., Cook, J., Bergmann-Leitner, E., Olotu, A., Lusingu, J., Mwacharo, J., Vekemans, J., Njuguna, P., Leach, A., Lievens, M., Dutta, S., von Seidlein, L., Savarese, B., Villafana, T., Lemnge, M. M., Cohen, J., Marsh, K., Corran, P. H., Angov, E., . . . Drakeley, C. J. (2011). Effect of the Pre-erythrocytic Candidate Malaria Vaccine RTS,S/AS01E on Blood Stage Immunity in Young Children. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jir222

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.